Safety and cardiovascular effects of multiple‐dose administration of aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021 - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library

Por um escritor misterioso
Last updated 13 janeiro 2025
Safety and cardiovascular effects of multiple‐dose administration of  aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021  - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
Safety and cardiovascular effects of multiple‐dose administration of  aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021  - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders - Juza - 2023 - Medicinal Research Reviews - Wiley Online Library
Safety and cardiovascular effects of multiple‐dose administration of  aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021  - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
PDF) The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomised multiple‐dose trial
Safety and cardiovascular effects of multiple‐dose administration of  aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021  - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
Auditory mismatch responses are differentially sensitive to changes in muscarinic acetylcholine versus dopamine receptor function
Safety and cardiovascular effects of multiple‐dose administration of  aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021  - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity
Safety and cardiovascular effects of multiple‐dose administration of  aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021  - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders - Juza - 2023 - Medicinal Research Reviews - Wiley Online Library
Safety and cardiovascular effects of multiple‐dose administration of  aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021  - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders - Juza - 2023 - Medicinal Research Reviews - Wiley Online Library
Safety and cardiovascular effects of multiple‐dose administration of  aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021  - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
PDF) Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial
Safety and cardiovascular effects of multiple‐dose administration of  aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021  - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
Schizophrenia and Related Psychoses - Major Reference Works - Wiley Online Library
Safety and cardiovascular effects of multiple‐dose administration of  aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021  - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
Beyond 52-Week Long-Term Safety: Long-Term Outcomes of Aripiprazole Lauroxil for Patients With Schizophrenia Continuing in an Extension Study
Safety and cardiovascular effects of multiple‐dose administration of  aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021  - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library
Synthesis and Characterization of 5-(2-Fluoro-4-[11C]methoxyphenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridine-7-carboxamide as a PET Imaging Ligand for Metabotropic Glutamate Receptor 2

© 2014-2025 trend-media.tv. All rights reserved.